0 Комментарии
0 Поделились
855 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
- Статьи пользователей
- Offers
- Jobs
- Войдите, чтобы отмечать, делиться и комментировать!
- Influenza Drug Market Expands as Seasonal Flu Prevention Remains a Healthcare PriorityAccording to the latest report published by Data Bridge Market Research, the Influenza Drug Market CAGR Value The wide ranging Influenza Drug Market report provides an overview of the Influenza Drug Market industry which is gaining momentum in the last few years. This report contains the list of leading competitors, strategic industry analysis and the insights of key...0 Комментарии 0 Поделились 264 Просмотры 0 предпросмотр
- Influenza Drug Market Grows as Seasonal Flu Prevention and Treatment Demand RisesAccording to the latest report published by Data Bridge Market Research, the Influenza Drug Market CAGR Value Winning Influenza Drug Market research report is a persuaded solution to have top-quality market research data that suits best to the business needs. The verified, best and advanced methods and tools such as SWOT analysis and Porter's Five Forces Analysis are used...0 Комментарии 0 Поделились 229 Просмотры 0 предпросмотр
- Preparedness Initiatives Boost the Viral Hemorrhagic Fever MarketAccording to the latest report published by Data Bridge Market Research, the Viral Hemorrhagic Fever Market CAGR Value The persuasive Viral Hemorrhagic Fever Market report covers several topics including market trend analysis, market drivers, market restraints, opportunities, threats, application analysis, emerging markets, and futuristic market scenario. Moreover, it...0 Комментарии 0 Поделились 105 Просмотры 0 предпросмотр
- RdRp Inhibitor Market to Reach USD 521.68 Million by 2028 | CAGR 8.2%According to a newly published market research report by 24LifeSciences, global RdRp inhibitor market was valued at USD 352.14 million in 2023 and is projected to reach USD 521.68 million by 2028, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 2024-2028. RNA-dependent RNA polymerase (RdRp) inhibitors represent a critical antiviral therapy class that prevents...0 Комментарии 0 Поделились 489 Просмотры 0 предпросмотр
- Respiratory Tract Infection Treatment Market to Reach USD 13.5 Billion by 2031 | CAGR 4.7%According to a newly published market research report by 24LifeSciences, global respiratory tract infection treatment market was valued at USD 9.8 billion in 2024 and is projected to reach USD 13.5 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 20252031. Respiratory tract infections (RTIs) remain among the most common infectious diseases...0 Комментарии 0 Поделились 795 Просмотры 0 предпросмотр
- Viral Hemorrhagic Fever Market Gains Focus Amid Growing Infectious Disease Preparedness EffortsAccording to the latest report published by Data Bridge Market Research, the Viral Hemorrhagic Fever Market CAGR Value Viral Hemorrhagic Fever Market analysis report contains significant data, current market trends, market environment, technological innovation, upcoming technologies and the technical progress in the allied industry. All this data and information is very...0 Комментарии 0 Поделились 451 Просмотры 0 предпросмотр
- What Are the Latest Trends in Europe Antiviral Drugs Market for Infectious Disease Treatment?Europe Antiviral Drugs Market Summary: According to the latest report published by Data Bridge Market Research, the Europe Antiviral Drugs Market CAGR Value Data Bridge Market Research analyzes that the Europe antiviral drugs market is expected to reach the value of USD 22,549.32 million by 2030, with a CAGR of 5.3% during the forecast period. Europe Antiviral Drugs Market is the...0 Комментарии 0 Поделились 306 Просмотры 0 предпросмотр